Τετάρτη 6 Ιουνίου 2018

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG‐asparaginase, and doxorubicin

Pediatric Blood &Cancer, EarlyView.


https://ift.tt/2Jm4fBr

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου